Two ZS Pharma Execs Picked for Allakos Management Team

Robert Alexander has been named CEO of San Carlos, CA, drug developer Allakos. Alexander most recently served as CEO of Coppell, TX-based ZS Pharma, a subsidiary of AstraZeneca (NYSE: [[ticker:AZN]]). Before joining ZS Pharma, Alexander was a director at Alta Partners, a venture capital firm. Allakos is developing therapeutic antibody drugs to treat allergic and inflammatory diseases.

Allakos also announced that Adam Tomasi has been hired as chief operating officer and chief financial officer. Tomasi was previously chief scientific officer and head of corporate development at ZS Pharma.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan